| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 161 |
| 1 | INSULIN GLARGINE | 150 |
| 2 | INSULIN LISPRO | 150 |
| 3 | VALSARTAN | 150 |
| 4 | LOSARTAN | 147 |
| 5 | VALSARTAN ORAL | 143 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 136 |
| 7 | INSULIN HUMAN | 136 |
| 8 | ISOTRETINOIN | 132 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 111 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESOMEPRAZOLE SODIUM | 57 | 0.0234 |
| 1 | BETAXOLOL | 6 | 0.0073 |
| 2 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 69 | 0.0047 |
| 3 | CLINDAMYCIN PHOSPHATE | 21 | 0.0038 |
| 4 | ANIDULAFUNGIN | 6 | 0.0037 |
| 5 | ROSUVASTATIN CALCIUM | 108 | 0.0037 |
| 6 | INSULIN HUMAN | 136 | 0.0034 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 28 | 0.0034 |
| 8 | ISOTRETINOIN | 132 | 0.0026 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 111 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 185 |
| 1 | Insulin Analog [EPC] | 176 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 163 |
| 3 | Proton Pump Inhibitor [EPC] | 156 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 139 |
| 5 | Insulin [EPC] | 137 |
| 6 | Retinoid [EPC] | 134 |
| 7 | Benzodiazepine [EPC] | 101 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 80 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 74 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 1 | Insulin [EPC] | 137 | 0.0030 |
| 2 | Antileishmanial [EPC] | 1 | 0.0026 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 4 | Actinomycin [EPC] | 4 | 0.0018 |
| 5 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 7 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 8 | Tetracycline-class Antibacterial [EPC] | 9 | 0.0011 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |